ScoreWhy is Hunan Jiudian Pharmaceutical Co., Ltd. ?
1
With a fall in Net Sales of -14.48%, the company declared Very Negative results in Mar 26
- ROCE(HY) Lowest at 15.12%
- INTEREST COVERAGE RATIO(Q) Lowest at 895.12
- RAW MATERIAL COST(Y) Grown by 7.5% (YoY)
2
Below par performance in long term as well as near term
- Along with generating -34.94% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hunan Jiudian Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hunan Jiudian Pharmaceutical Co., Ltd.
-37.62%
-2.02
28.84%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
22.56%
EBIT Growth (5y)
29.99%
EBIT to Interest (avg)
23.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
1.03
Tax Ratio
10.20%
Dividend Payout Ratio
41.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.98%
ROE (avg)
18.06%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.77
EV to EBIT
10.93
EV to EBITDA
8.92
EV to Capital Employed
1.78
EV to Sales
1.56
PEG Ratio
NA
Dividend Yield
3.08%
ROCE (Latest)
16.29%
ROE (Latest)
14.80%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 681.47 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 6.6 times
-28What is not working for the Company
ROCE(HY)
Lowest at 13.15%
RAW MATERIAL COST(Y)
Grown by 20.12% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 2.33 %
NET SALES(Q)
Fallen at -15.24%
INTEREST(Q)
Highest at CNY 8.23 MM
PRE-TAX PROFIT(Q)
Fallen at -34.57%
NET PROFIT(Q)
Fallen at -37.86%
Here's what is working for Hunan Jiudian Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 681.47 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Highest at 6.6 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Hunan Jiudian Pharmaceutical Co., Ltd.
Interest
At CNY 8.23 MM has Grown at 23.94%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Fallen at -15.24%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Interest
Highest at CNY 8.23 MM
in the last five periods and Increased by 23.94% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Pre-Tax Profit
Fallen at -34.57%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Fallen at -37.86%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at 2.33 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 20.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
